Clomid (containing clomiphene citrate) |
E. coli uvrA, recA and wild-type |
Increased DNA strand breaks |
Ohnishi et al. (1986) |
Clomiphene citrate |
S. typhimurium TA 97, 100, 1538 |
Incraesed frameshift mutations no icrease in base pair substitution type mutations |
Ohnishi et al. (1986) |
Clomiphene citrate |
E. coli PolA− PolA+ |
Increased genolethal DNA damage |
Ohnishi et al. (1986) |
Clomiphene citrate |
Rat bone marrow cells |
Increased micronucleus formation |
Duran et al. (2006) |
Clomiphene citrate |
E. coli TA 97, TA 100 |
No evidence for Frameshift mutations and base pair substitution type mutations |
Yilmaz et al. (2014) |
Clomiphene citrate |
Human lymphocytes |
Significantly incraesed chromosomal aberrations micronucleus sister chromatid exchanges |
Yilmaz et al. (2014) |
Clomiphene citrate |
Human prostate cancer cells |
Mild cytotoxicity |
Jiann et al. (2002) |
Clomiphene citrate |
Breast cancer cells |
Apoptotic |
Elloumi-Mseddi et al. (2015) |
Clomiphene citrate |
Human peripheral blood mononuclear cells |
Cytotoxic |
Costa et al. (2012) |
Clomiphene citrate |
Pregnant mouse |
Embryotoxic teratogenic |
Ara and Asmatullah (2011) |